Heavy tamponade 1: A review of indications, use, and complications

Eye

Volumn 22, Issue 10, 2008, Pages 1342-1359

  Heimann, H ^a   Stappler, T ^a   Wong, D ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKANE DERIVATIVE; ALKENE DERIVATIVE; BIOMEDICAL AND DENTAL MATERIALS; DAUNORUBICIN; FLUOROCARBON; FLUOROSILICONE; FLUOROURACIL; HEAVY TAMPONADE; LOW MOLECULAR WEIGHT HEPARIN; PERFLUORODECALIN; PERFLUOROPHENANTHRENE; SILICONE OIL; UNCLASSIFIED DRUG;

ANTERIOR EYE CHAMBER; CATARACT; CLINICAL TRIAL; CONFERENCE PAPER; CORNEA INJURY; CORNEA OPACITY; DISEASE COURSE; EMULSION; EYE FUNDUS; EYE INFLAMMATION; FOLLOW UP; HUMAN; INCIDENCE; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; ISCHEMIC OPTIC NEUROPATHY; KERATOPATHY; PHYSICAL CHEMISTRY; POSTERIOR EYE CHAMBER; RECURRENT DISEASE; RETINA ARTERY OCCLUSION; RETINA DETACHMENT; RETINA NECROSIS; SAFETY; SURGICAL TECHNIQUE; TREATMENT INDICATION; VITREORETINOPATHY;

EID: 54049137046     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.61     Document Type: Conference Paper

References (62)

1. Bhisitkul RB, Gonzalez VH. 'Heavy oil' for intraocular tamponade in retinal detachment surgery. Br J Ophthalmol 2005; 89(6): 649-650.
2. Heimann K Editorial. Graefe's Arch Clin Exp Ophthalmol 1993; 231: 613-614.
3. Scott JD. Fluorosilicone oil for retinal detachment. Br J Ophthalmol 1990; 74(11): 641-642.
4. Bottoni F, Bailo G, Arpa P, Prussiani A, Monticelli M, de Molfetta V. Management of giant rednal tears using perfluorodecalin as a postoperative short-term vitreoretinal tamponade: A long-term follow-up study. Ophthalmic Surg 1994; 25(6): 365-373.
5. Bottoni F, Sborgia K Arpa. F, De Casa N, Bertazzi E, Monticelli M et al. Perfluorocarbon liquids as postoperative short term vitreous substitutes in complicated retinal detachment. Graefes Arch Clin Exp Ophthalmol 1993; 231(11): 619-628.
6. Gremillion Jr CM, Peyman GA, Liu KR, Naguib KS. Fluorosilicone oil in the treatment of retinal detachment. Br J Ophthalmol 1990; 74 (11): 643-646.
7. Kertes PJ, Wafapoor H, Peyman GA, Calixto Jr N, Thompson H. The management Of giant retinal tears using perfluoroperhydrophenanthrene. A multicenter case series. Vitreon Collaborative Study Group. Ophthalmology 1997; 104(7): 1159-1165.
8. Peyman GA, Smith RT, Charles H. Injection of fluorosilicone oil and pars Plana vitrectomy for complex retinal detachment. Can J Ophthalmol 1987; 22(5): 276-278.
9. Batman C, Cekic O. Effects of the long-term use of perfluoroperhydrophenanthrene on the retina. Ophthalmic Surg Lasers 1998; 29(2): 144-446.
10. Viebahn M, Buellner H. Perfluoroperhydrophenanthrene unsuitable for postoperative retinal tamponade. Am J Ophthalmol 1994; 118 (1): 124-126.
11. Kirchhof B, Wong D, Van Meurs J, Hilgers RD, Macek M, Lois N et al Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol 2002; 133(1): 95-101.
12. Stefaniotou MI, Aspiotis MV, Kitsos GD, Kalogeropoulos CD, Asproudis IC, Psilas KG. Our experience with perfluorohexyloctane (F6H8) as a temporary endotamponade in vitreoretinal surgery. Eur J Ophthalmol 2002; 12(6): 518-522.
13. Gerding H, Kolck A. [Perfluorohexyloctane as internal tamponade in patients with complicated retinal detachment. Results after 6 months). Ophthalmologe 2004; 101(3): 255-262.
14. Roider J, Hoerauf H, Kobuch K, Gabel VP. Clinical findings on the use of long-term heavy tamponades (semifluorinated alkanes and their oligorners) in complicated retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol 2002, 240(12): 965-971.
15. Schatz B, EI-Shabrawi Y, Haas A, Langmann G. Adverse side effects with perfluorohexyloctane as a long-term tamponade agent in complicated vitreoretinal surgery Retina 2004; 24(4): 567-573.
16. Vote B, Wheen L, Cluroe A, Teoh H, McGeorge A. Further evidence for proinflammatory nature of perfluorohexyloctane in the eye. Clin Experiment Ophthalmol 2003; 31(5): 408-414.
17. Hoerauf H, Roider J, Kobuch & Laqua H. Perfluorohexylethan (O62) as ocular endotamponade in complex vitreoretinal surgery. Retina 2005; 25(4): 479-488.
18. Rizzo S, Genovesi-Ebert F, Belting C. The combined use of perfluorohexyloctane (F6H8) and silicone oil as an intraocular tamponade in the treatment of severe retinal detachment. Graefts Arch Clin Exp Ophthalmol 2006; 244(6): 709-716.
19. Wetterqvist C, Wong D, Williams R, Stappler T, Herbert E, Freeburn S. Tamponade efficiency of perfluorohexyloctane and silicone oil solutions in a model eye chamber. Br J Ophthalmol 2004; 88(5): 692-696.
20. Wolf S, Schon V, Meier P, Wiedemann P. Silicone oil-RMN3 mixture ('heavy silicone oil') as internal tamponade for complicated refinal detachment. Retina 2003; 23(3): 335-342.
21. Wong D, Van Meurs JC, Stappler T, Groenewald C, Pearce IA, McGalliard JN et al. A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent. Br J Ophthalmol 2005; 89(6): 662-665.
22. Rizzo S, Genovesi-Ebert F, Vento A, Cresti F, Di Bartolo E, Belting C. A new heavy silicone oil (HWS 46-3000) used as a prolonged interrial tamponade agent in complicated vitreoretinal surgery: A pilot study. Retina 2007; 27(5): 613-620.
23. Herbrig E, Sandner D, Engelmann K. Anatomical and functional results of endotamponade with heavy silicone oil - Densiron 68 - in complicated retinal detachment. Ophthalmic Res 2007; 39(4): 198-206.
24. Lappas A, Kirchhof B, Konen W. [Effects of the long-term tamponade with Densiron on the lens]. Klin Monatsbl Augenheilkd 2007; 224 (5): 434-437.
25. Sandner D, Engelmann K. First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment. Graefes Arch Clin Exp Ophthalmol 2006; 244(5): 609-619.
26. Sandner D, Herbrig E, Engelmann K. High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up. Graefes Arch Clin Exp Ophthalmol 2007, 245(8): 1097-1105.
27. Theelen T, Tilanus MA, Klevoring BJ. Intraocular inflammation following endotamponade with high-density silicone oil. Graefes Arch Clin Exp Ophthalmol 2004; 242(7): 617-620.
28. Mackiewicz J, Muhling B, Hiebl W, Meinert H, Maaijwee K, Kociok N et al. In vivo retinal tolerance of various heavy silicone oils. Invest Ophthalmol Vis Sci 2007; 48(4): 1873-1883.
29. Soman N, Banerjee R. Artificial vitreous replacements. Biomed Mater Eng 2003; 13(1): 59-74.
30. Wong D, Lois N. Perfluorocarbons and semifluorinated alkanes. Semin Ophthalmol 2000; 15(1): 25-35.
31. Fawcett IM, Williams RL, Wong D. Contact angles of substances used for internal tamponade in retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol 1994; 232(7): 438-444.
32. Rizzo S, Genovesi-Ebert F, Belting C, Vento A, Cresti F. A pilot study on the use of silicone oil-RMN3 as heavier-than-water endotamponade agent. Graefes Arch Clin Exp Ophthalmol 2005; 243(11): 1153-1157.
33. Rizzo S, Genovesi-Ebert F. Belting C, Foltran F, Gandolfo E, Lesnoni G et al. Long-term vitreous replacement with perfluorohexyloctane and silicone oil: Preliminary reports of a multicentric study. Ophthalmologica 2005; 219(3): 147-153.
34. Tognetto D, Minutola D, Sanguinetti G, Ravalico G. Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment: A pilot study. Ophthalmology 2005; 112(9): 1574.
35. Cheung BT, Lai TY, Yuen CY, Lai WW, Tsang CW, Lam DS. Results of high-density silicone oil as a tamponade agent in macular hole retinal detachment in patients with high myopia. Br J Ophthalmol 2007; 91(6): 719-721.
36. Alexander P, Prasad R, Ang A, Poulson AV, Scott JD, Snead MP. Prevention and control of proliferative vitreoretinopathy: Primary retinal detachment surgery using silicone oil as a planned two-stage procedure in high-risk cases. Eye, 2 February 2007; [e-pub ahead of print].
37. Joeres S, Kirchhof B, Joussen AM. PVR as a complication of rhegmatogeneous retinal detachment: A solved problem? Br J Ophthalmol 2006; 90(6): 796-797.
38. Wiedemann P, Leinung C, Hilgers RD, Heimann K. Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 1991; 229(2): 150-152.
39. Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT et al. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: Results from a randomized, double-blind, controlled clinical trial. Ophthalmology 2001; 108(7): 1179-1183.
40. Chang S, Ozmert E, Zimmerman NJ. Intraolperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy. Am J Ophthalmol 1988; 106(6): 668-674.
41. Peyman GA, Smith RT. Use of fluorosilicone to unfold a giant retinal tear. Int Ophthalmol 1987, 10(3): 149-151.
42. Eckardt C, Nicolai U. [Clinical and histologic findings after several weeks of intraocular tamponade with perfluorodecalin]. Ophthalmologe 1993; 90(5): 443-47.
43. Sirimaharaj M, Balachandran C, Chan WC, Hunyor AP, Chang AA, Gregory-Roberts J et al. Vitrectomy with short term postoperative tamponade using perfluorocarbon liquid for giant retinal team. Br J Ophthalmol 2005; 89(9): 1176-1179.
44. Meinert H, Roy T. Semifluorinated alkanes - a new class of compounds with outstartding properties for use in ophthalmology. Eur J Ophthalmol 2000; 10(3): 189-197.
45. Hiscott P, Magee RM, Colthurst M, Lois N, Wong D. Clinicopathological correlation of epiretinal membranes and posterior lens opacification following perfluorohexyloctane tamponade. Br J Ophthalmol 2001; 85(2): 179-183.
46. Herbert E, Stappler T, Wetterqvist C, Williams F. Wong D. Tamponade properties of double-filling with perfluorohexyloctane and silicone oil in a model eye chamber. Graefes Arch Clin Exp Ophthalmol 2004; 242(3): 250-254.
47. De Molfetta V, Bottoni F, Arpa P, Vinciguerra P, Zenoni S. The effect of simultaneous internal tamponade on fluid compartmentalization and its relationship to cell proliferation. Retina 1992; 12(3 Suppl): S40-S45.
48. Bottoni F, Arpa P, Vinciguerra P, Zenoni S, De Molfetta V. Combined silicone and fluorosilicone oil tamponade (double filling) in the management of complicated retinal detachment. Ophthalmologica 1992; 204(2): 77-81.
49. Pagot-Mathis V, Benouaich X, Mathis A, Rico-Lattes I, Dumoulin A. [Management of complicated retinal detachment using a heavy silicon oil as temporary tamponade]. J Fr Ophtalmol 2006; 29(2): 137-145.
50. Rizzo S, Belting C, Genovesi-Ebert F, Cresti F, Vento A, Martini R. Successful treatment of persistent macular holes using 'heavy silicone oil' as intraocular tamponade. Retina 2006; 26(8): 905-908.
51. Kim YK, Gunther B, Meinert H. A new, heavier-than-water silicone oil: A solution of perfluorohexyloctane in polydimethylsiloxane. Eur J Ophthalmol 2005; 15(5): 627-637.
52. Majid MA, Hussin HM, Biswas S, Haynes RJ, Mayer EJ, Dick AD. Emulsification of Densiron-68 used in inferior retinal detachment surgery. Eye 2007; 22(1): 152-157.
53. Wong D, Cazabon S, Ali H, Kumar I, Valldeperas X, Groenewald C et al Can the sequential use of conventional silicone oil and heavy oil be a strategy for the management of proliferative vitreoretinopathy? Ann Acad Med Singapore 2006; 35(3): 181-184.
54. Joussen AM, Kirchhof B, Schrage N, Ocklenburg C, Hilgers RD. Heavy silicone oil versus standard silicone oil as vitreous tamponade in inferior PVR (HSO Study): Design issues and implications. Acta Ophthalmol Scand 2007; 85(6): 623-630.
55. Dresp JH, Menz DH. Interaction of different mular endotamponades as a risk factor for silicone oil emulsification. Retina 2005; 25 (7): 902-910.
56. Dresp JH, Menz DH. The phenomenon of 'sticky' silicone oil. Graefes Arch Clin Exp Ophthalmol 2007; 245(6): 863-868.
57. Wong D, Williams RL, German MJ. Exchange of perfluorodecalin for gas or oil: A model for avoiding slippage. Graefes Arch Clin Exp Ophthalmol 1998; 236(3): 234-237.
58. Scott IU, Flynn Jr HW, Murray TG, Peuer WJ. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: A multicenter study. Am J Ophthalmol 2003; 136(3): 454-463.
59. Helbig H, Kellner U, Bornfeld N, Foerster MH. Cataract surgery and YAG-laser capsulotomy following vitrectomy for diabetic retinopathy. Ger J Ophthalmol 1996; 5(6): 408-414.
60. Wickham L, Asaria RH, Alexander R, Luthert P, Charteris DG. Immunopathology of intraocular silicone oil: Enucleated eyes. Br J Ophthalmol 2007; 91(2): 253-257.
61. Stolba U, Krepler K, Velikay-Parel M, Binder S. The effect of specific gravity of perfluorocarbon liquid on the retina after experimental vitreous substitution. Graefes Arch Clin Exp Ophthalmol 2004; 242(11): 931-936.
62. Martinez-Castillo V, Boixadera A, Verdugo A, Garcia-Arumi J. Pars plana vitrectomy alone for the management of inferior breaks in pseudophakic retinal detachment without facedown position. Ophthalmology 2005; 112(7): 1222-1226.